Pharmabiz

UK MHRA calls on public to report side effects and suspected fakes during #MedSafetyWeek

UK MHRA calls on public to report side effects and suspected fakes during #MedSafetyWeek: United Kingdom Tuesday, November 4, 2025, 15:00 Hrs [IST] The Medicines and Healthcare pr ...
Pharmabiz

MedGenome invests into Gujarat-based diagnostics chain Green Cross to expand genomics offerings across India

MedGenome invests into Gujarat-based diagnostics chain Green Cross to expand genomics offerings across India: Our Bureau, Bengaluru Tuesday, November 4, 2025, 14:15 Hrs [IST] MedG ...
Pharmabiz

Merck Foundation launches $22 million initiative to improve cardiovascular care in the US

Merck Foundation launches $22 million initiative to improve cardiovascular care in the US: Rahway, New Jersey Tuesday, November 4, 2025, 14:00 Hrs [IST] The Merck Foundation annou ...
Pharmabiz

University of Glasgow scientists use AI to study the intricate language of biomolecules

University of Glasgow scientists use AI to study the intricate language of biomolecules: Our Bureau, Bengaluru Tuesday, November 4, 2025, 14:15 Hrs [IST] University of Glasgow sci ...
Pharmabiz

SS Innovations with Cardiac Surgeons in Mumbai showcase future of robotic cardiac care through CME

SS Innovations with Cardiac Surgeons in Mumbai showcase future of robotic cardiac care through CME: Our Bureau, Mumbai Monday ...
Pharmabiz

Dr Ratankanvar H Gadhavicharan appointed as new Commissioner of Gujarat FDCA

Dr Ratankanvar H Gadhavicharan appointed as new Commissioner of Gujarat FDCA: Our Bureau, Mumbai Monday, November 3, 2025, 16 ...
Pharmabiz

Major change for rare disease treatments on way, signals MHRA

Major change for rare disease treatments on way, signals MHRA: United Kingdom Tuesday, November 4, 2025, 13:00 Hrs [IST] The rulebook for rare disease therapies will be overhauled ...
Pharmabiz

Roche’s phase III ALLEGORY study of Gazyva/Gazyvaro in adults with systemic lupus erythematosus meets its primary endpoint

Roche’s phase III ALLEGORY study of Gazyva/Gazyvaro in adults with systemic lupus erythematosus meets its primary endpoint: Basel Tuesday, November 4, 2025, 12:00 Hrs [IST] Roch ...
Pharmabiz

Merz Aesthetics introduces new Belotero syringe offering greater precision, comfort and ease of use

Merz Aesthetics introduces new Belotero syringe offering greater precision, comfort and ease of use: Raleigh, North Carolina Tuesday, November 4, 2025, 11:00 Hrs [IST] Merz Aesthe ...
Pharmabiz

China NMPA grants breakthrough therapy designation to Akeso’s ivonescimab for first-line treatment of triple-negative breast cancer

Ivonescimab combined with chemotherapy for locally advanced or metastatic NSCLC resistant to EGFR-TKI therapy, which has now been approved for marketing in China and added to China’s National ...
Pharmabiz

World Health Organization issues guidance to address drastic global health financing cuts

Ghana lifted the cap on excise tax earmarked for its national health insurance agency, resulting in a 60% budget increase. The country also launched “the Accra Reset”, a bold framework to reimagine ...
Pharmabiz

Indian healthcare industry shifts from capital-intensive to asset-light infrastructure model: Varun Dubey

Indian healthcare industry shifts from capital-intensive to asset-light infrastructure model: Varun Dubey: Nandita Vijayasimha, Bengaluru Tuesday, November 4, 2025, 08:00 Hrs [IST ...